loadpatents
name:-0.01766300201416
name:-0.010756015777588
name:-0.0027430057525635
Fairlie; David Patent Filings

Fairlie; David

Patent Applications and Registrations

Patent applications and USPTO patent grants for Fairlie; David.The latest application filed is for "modulators of protease activated receptors".

Company Profile
3.10.16
  • Fairlie; David - Brisbane AU
  • Fairlie; David - Mt Ommaney AU
  • - Mt. Ommaney AU
  • FAIRLIE; David - Springwood AU
  • Fairlie; David - Queensland AU
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Modulators of protease activated receptors
Grant 9,868,763 - Fairlie , et al. January 16, 2
2018-01-16
Modulators of C3a receptors
Grant 9,586,914 - Fairlie , et al. March 7, 2
2017-03-07
Nociceptin mimetics
Grant 08921306 -
2014-12-30
Nociceptin mimetics
Grant 8,921,306 - Fairlie , et al. December 30, 2
2014-12-30
Modulators Of Protease Activated Receptors
App 20140315796 - Fairlie; David ;   et al.
2014-10-23
Modulators Of C3a Receptors
App 20140302069 - Fairlie; David ;   et al.
2014-10-09
Nociceptin Mimetics
App 20130157928 - Fairlie; David ;   et al.
2013-06-20
Cyclic Agonists And Antagonists Of C5a Receptors And G Protein-coupled Receptors
App 20130005644 - FAIRLIE; David ;   et al.
2013-01-03
Cyclic Peptides As G-Protein Coupled Receptor Antagonists
App 20120302493 - Taylor; Stephen Maxwell ;   et al.
2012-11-29
Cyclic Peptides As G-protein Coupled Receptor Antagonists
App 20100331236 - Taylor; Stephen Maxwell ;   et al.
2010-12-30
Treatment Of Osteoarthritis
App 20100267639 - Shiels; Ian Alexander ;   et al.
2010-10-21
Cyclic agonists and antagonists of C5A receptors and G Protein-coupled receptors
Grant RE41,287 - Fairlie , et al. April 27, 2
2010-04-27
Treatment of osteoarthritis
Grant 7,659,246 - Shiels , et al. February 9, 2
2010-02-09
Cyclic peptides as G-protein-coupled receptor antagonists
Grant 7,579,432 - Taylor , et al. August 25, 2
2009-08-25
CYCLIC AGONISTS AND ANTAGONISTS OF C5a RECEPTORS AND G PROTEIN-COUPLED RECEPTORS
App 20090203760 - FAIRLIE; David ;   et al.
2009-08-13
Methods For Treating And Ameliorating The Symptons Of Inflammatory Bowel Diseases
App 20090004264 - Woodruff; Trent Martin ;   et al.
2009-01-01
Treatment of inflammatory bowel disease
Grant 7,410,945 - Woodruff , et al. August 12, 2
2008-08-12
Anti-Cancer Agents
App 20080004290 - Fairlie; David ;   et al.
2008-01-03
Treatment of osteoarthritis
App 20060234921 - Shiels; Ian Alexander ;   et al.
2006-10-19
Cyclic peptides as g-protein-coupled receptor antagonists
App 20060217530 - Maxwell; Stephen ;   et al.
2006-09-28
Cyclic agonists and antagonists of C5a receptors and G protein-coupled receptors
App 20060160726 - Fairlie; David ;   et al.
2006-07-20
Treatment of inflammatory bowel disease
App 20060135411 - Woodruff; Trent Martin ;   et al.
2006-06-22
Cyclic agonists and antagonists of C5a receptors and G protein-coupled receptors
Grant 6,821,950 - Fairlie , et al. November 23, 2
2004-11-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed